Full Doc
 | 2008 |
Technology License Contract
Technology License Contract (24K)
Doc #3787220: This document is immediately available for purchase, but does not have a preview available for viewing.
3787220
| | |
Full Doc
 | 2007 |
Technology License Agreement
Technology License Agreement (47K)
Doc #2786789: This document is immediately available for purchase, but does not have a preview available for viewing.
2786789
| | |
Preview
Full Doc
 | 2007 |
Technology License Agreement
Technology License Agreement (18K)
Doc #3030771: Click preview link for longer preview.
[Translation of Chinese original]
Technology License Agreement
This Agreement is entered into by the following parties on June 7, 2004 in Beijing, the People�s Republic of China (the �PRC�, for the purposes of this Agreement, not including Hong Kong Special Administrative Region, Macao Special Administrative Region and Taiwan):
Licensor: Beijing Novel-Tongfang Digital TV Technology Co., Ltd., a limited liability company duly incorporated and validly existing under the PRC law, whose registered office is at Jingmeng Hi-Tech Building B, Room 402, No.5, Shangdi East Road, Haidian . . .
3030771
| | |
Preview
Full Doc
 | 2007 |
Technology License Agreement
Technology License Agreement (24K)
Doc #3109891: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This TECHNOLOGY LICENSE AGREEMENT (the �Agreement�), dated as of March 3, 1999 (the �Effective Date�), is made by and between Analog Devices, Inc., a Massachusetts corporation having a business address at One Technology Way, Norwood, Massachusetts 02062 (�Analog�), and MEMSIC, Inc., a Delaware corporation having a business address at 21 Osborn Street, Cambridge, Massachusetts 02139 (�Licensee�).
WHEREAS, Analog and Licensee have entered into that certain Series A Convertible Preferred Stock and Warrant Purchase Agreement dated as of the date hereof (the . . .
3109891
| | |
Full Doc
 | 2007 |
Technology License Agreement
Technology License Agreement (14K)
Doc #3134461: This document is immediately available for purchase, but does not have a preview available for viewing.
3134461
| | |
Full Doc
 | 2007 |
Technology License Agreement
Technology License Agreement (14K)
Doc #3137915: This document is immediately available for purchase, but does not have a preview available for viewing.
3137915
| | |
Preview
Full Doc
 | 2007 |
Technology License Agreement
Technology License Agreement (24K)
Doc #3168673: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This TECHNOLOGY LICENSE AGREEMENT (the �Agreement�), dated as of March 3, 1999 (the �Effective Date�), is made by and between Analog Devices, Inc., a Massachusetts corporation having a business address at One Technology Way, Norwood, Massachusetts 02062 (�Analog�), and MEMSIC, Inc., a Delaware corporation having a business address at 21 Osborn Street, Cambridge, Massachusetts 02139 (�Licensee�).
WHEREAS, Analog and Licensee have entered into that certain Series A Convertible Preferred Stock and Warrant Purchase Agreement dated as of the date hereof (the . . .
3168673
| | |
Preview
Full Doc
 | 2007 |
Technology License
Technology License (56K)
Doc #3199807: Click preview link for longer preview.
TECHNOLOGY LICENSE
THIS TECHNOLOGY LICENSE (as amended, modified, supplemented or restated from time to time, this "Agreement") is made and entered into as of the 12th day of February, 2007, by and between Gemini Environmental Corporation, a corporation organized under the laws of the State of Delaware ("Licensor"), and Full Circle Industries, Inc., a corporation organized under the laws of the State of Nevada ("Licensee"). Licensor and Licensee are sometimes hereinafter referred to individually as a "Party" and collectively as the "Parties."
RECITALS
WHEREAS, Licensee . . .
3199807
| | |
Preview
Full Doc
 | 2007 |
Technology License
Technology License (56K)
Doc #3199809: Click preview link for longer preview.
TECHNOLOGY LICENSE
THIS TECHNOLOGY LICENSE (as amended, modified, supplemented or restated from time to time, this "Agreement") is made and entered into as of the 12th day of February, 2007, by and between Gemini Environmental Corporation, a corporation organized under the laws of the State of Delaware ("Licensor"), and Full Circle Industries, Inc., a corporation organized under the laws of the State of Nevada ("Licensee"). Licensor and Licensee are sometimes hereinafter referred to individually as a "Party" and collectively as the "Parties."
RECITALS
WHEREAS, Licensee . . .
3199809
| | |
Preview
Full Doc
 | 2007 | | | |
Preview
Full Doc
 | 2007 | | | |
Full Doc
 | 2006 |
Technology License Agreement
Technology License Agreement (10K)
Doc #2635925: This document is immediately available for purchase, but does not have a preview available for viewing.
2635925
| | |
Full Doc
 | 2006 |
Technology License Agreement
Technology License Agreement (10K)
Doc #2646884: This document is immediately available for purchase, but does not have a preview available for viewing.
2646884
| | |
Preview
Full Doc
 | 2006 |
Technology License
Technology License (64K)
Doc #2673709: Click preview link for longer preview.
TECHNOLOGY LICENSE
FROM
ARKENOL, INC.
IN FAVOR OF
BlueFire Ethanol, Inc.
FOR THE PROCESSING OF
CELLULOSE TO ETHANOL
IN NORTH AMERICA
Dated as of
March 1, 2006
TABLE OF CONTENTS
ARTICLE I DEFINITIONS AND INTERPRETATION
1
1.1 Terms Defined Above
1
1.2 Additional Defined Terms
1
1.3 References
5
1.4 Articles and Sections . . .
2673709
| |
Chase Manhattan
As referenced in this Technology License:
Chase Manhattan Bank, – trust, government or political subdivision thereof, Governmental Authority, or other entity.
"Prime Rate" shall mean the per annum rate of interest announced or published from time to time by The Chase Manhattan Bank, N.A., as its reference or prime rate.
"Process" shall mean the acid hydrolysis process for lignocellulosic materials as more particularly described on Exhibit A.
"Products" shall mean By- _____________
dt 1667370
|
Preview
Full Doc
 | 2005 |
Technology License Agreement
Technology License Agreement (57K)
Doc #625474: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This Technology License Agreement (the �Agreement�) is entered into as of March 18, 2005 (�Effective Date�) by Occam Networks, Inc., a Delaware corporation with a principal place of business at 77 Robin Hill Road, Santa Barbara, California 93117 (�Occam�), and Tellabs Petaluma, Inc., a Delaware corporation with a principal place of business at 1465 North McDowell Boulevard, Petaluma, California 94954 (�Tellabs�), on behalf of itself and its parent, subsidiaries, and affiliates such that each entity will be jointly and severally liable for the . . .
625474
|
Occam Networks
As referenced in this Technology License Agreement:
Occam Networks, Inc. – dex1069.htm TECHNOLOGY LICENSE AGREEMENT
Exhibit 10.69
CONFIDENTIAL TREATMENT
TECHNOLOGY LICENSE AGREEMENT
This Technology License Agreement (the Agreement) is entered into as of March 18, 2005 (Effective Date) by Occam Networks, Inc. , a Delaware corporation with a principal place of business at 77 Robin Hill Road, Santa Barbara, California 93117 (Occam), and Tellabs Petaluma, Inc., a Delaware corporation with a principal _____________
Occam Networks, Inc. – Omitted portions have been filed separately with the Commission.
-15-
CONFIDENTIAL TREATMENT
The parties have signed below to indicate their acceptance of the terms of this Agreement.
Tellabs Petaluma, Inc.
Occam Networks, Inc.
Name:
Name:
Title:
Title:
Signature:
Signature:
Date:
Date:
***
Confidential treatment requested pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. Omitted portions have been _____________
dt 1452635
| |
Preview
Full Doc
 | 2005 |
Technology License Agreement
Technology License Agreement (112K)
Doc #1049097: Click preview link for longer preview.
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
NOVATED AND RESTATED
TECHNOLOGY LICENSE AGREEMENT
dated as of June 9, 2005
among
EXELIXIS, INC.,
SYMPHONY EVOLUTION, INC.
and
SYMPHONY EVOLUTION HOLDINGS LLC
Table of Contents
. . .
1049097
|
Exelixis
As referenced in this Technology License Agreement:
EXELIXIS, INC – AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 OF THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.
NOVATED AND RESTATED
TECHNOLOGY LICENSE AGREEMENT
dated as of June 9, 2005
among
EXELIXIS, INC .,
SYMPHONY EVOLUTION, INC.
and
SYMPHONY EVOLUTION HOLDINGS LLC
Table of Contents
Page
Article 1
Definitions
1
Article 2
Grant Of Rights
1
2.1.
Assignment
1
2.2.
License _____________
Exelixis Inc – NOVATED AND RESTATED
TECHNOLOGY LICENSE AGREEMENT
This NOVATED AND RESTATED TECHNOLOGY LICENSE AGREEMENT (this Agreement) is made and effective as of June 9, 2005 (the Effective Date) by and among, Exelixis Inc ., a Delaware corporation (the Licensor), Symphony Evolution, Inc., a Delaware corporation (Symphony Evolution) (each of Licensor and Symphony Evolution being a Party, and collectively, the Parties), and Symphony Evolution _____________
Exelixis, Inc – service, or by registered or certified mail (return receipt requested), with postage and registration or certification fees thereon prepaid, addressed to the Party at its address set forth below:
Licensor:
Exelixis, Inc .
170 Harbor Way
South San Francisco, CA 94083
Attention: Corporate Secretary
Facsimile: (650) 837-7951
Symphony Evolution:
Symphony Evolution, Inc.
7361 Calhoun Place, Suite 325
Rockville, MD 20850
Attn: _____________
EXELIXIS, INC – Partners, L.P.,
its Manager
By:
Symphony Capital GP, L.P.,
its general partner
By:
Symphony GP, LLC,
its general partner
/s/ Mark Kessel
Name: Mark Kessel
Title: Managing Member
EXELIXIS, INC .
/s/ Christoph Pereira
Name: Christoph Pereira
Title: Vice President, Legal Affairs and Secretary
19
[ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED _____________
Exelixis, Inc – States Employee Retirement Income Security Act of 1974, as amended.
Exchange Act means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.
Exelixis means Exelixis, Inc ., a Delaware corporation.
Exelixis Common Stock means the common stock, par value $0.001 per share, of Exelixis.
Exelixis Common Stock Valuation has the meaning set forth in Section _____________
dt 1398443
;
Regents of UC
As referenced in this Technology License Agreement:
Regents of the University of California – has been in-licensed by Licensor from Yale University (Yale) pursuant to the Yale Exclusive License Agreement between Licensor and Yale effective January 9, 2002 (the Yale Agreement) and the Regents of the University of California (Regents) pursuant to the Exclusive License and Bailment Agreement between Licensor and Regents effective July 25, 2001 (the Regents Agreement and together with the Yale Agreement, the University Agreements).
_____________
dt 1534210
;
|
Yale
As referenced in this Technology License Agreement:
Yale University – Parties acknowledge and agree that the license set forth in Section 2.2 does not include certain Intellectual Property (the University IP) which has been in-licensed by Licensor from Yale University (Yale) pursuant to the Yale Exclusive License Agreement between Licensor and Yale effective January 9, 2002 (the Yale Agreement) and the Regents of the University of California (Regents) pursuant _____________
dt 1545736
;
JPMorgan Chase
As referenced in this Technology License Agreement:
JPMorgan Chase Bank – corporation, trust, estate, association, nominee or other entity.
Personnel of a Party means such Party, its employees, subcontractors, consultants, representatives and agents.
Prime Rate means the quoted Prime Rate at JPMorgan Chase Bank or, if such bank ceases to exist or is not quoting a base rate, prime rate reference rate or similar rate for United States dollar loans, such other major money _____________
dt 1406124
|
Preview
Full Doc
 | 2005 |
Technology License Agreement
Technology License Agreement (36K)
Doc #1238931: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
THIS TECHNOLOGY LICENSE AGREEMENT (this "License"), is made as of August 18, 2005 (the "Effective Date") by and among Epic Financial Corporation, a Nevada corporation ("Epic"), having an address at 7545 No. Del Mar Avenue, Suite 102, Fresno, California 93711, Inkway Corporation, a Nevada corporation ("Licensee"), a wholly-owned subsidiary of Epic, having an address at 7545 No. Del Mar Avenue, Suite 102, Fresno, California 93711, on one hand, and AccuBrite Inc., a New York corporation ("Licensor"), having an address at 7407 No. Woodson Avenue, Fresno, California . . .
1238931
| | |
Preview
Full Doc
 | 2004 |
Technology License Agreement
Technology License Agreement (28K)
Doc #281934: Click preview link for longer preview.
TECHNOLOGY LICENSE AGREEMENT
This Technology License Agreement (the �Agreement�) is entered into as of this 16th day of June, 2004 (�Effective Date�) by and between Biozyme Laboratories Ltd, a company organized under the laws of England and Wales company no. 1034731 whose registered office is situated at Unit 6, Gilchrist Thomas Estate Blaenavon, Gwent, NP4 9RL (�Biozyme�) and ISTA Pharmaceuticals, Inc., a Delaware corporation whose corporate office is situated at 15279 Alton Parkway, Suite 1001, Irvine, California 92618 (�ISTA�) .
RECITALS
WHEREAS, . . .
281934
|
ISTA Pharma
As referenced in this Technology License Agreement:
ISTA Pharmaceuticals, – England and Wales company no. 1034731 whose registered office is situated at Unit 6, Gilchrist Thomas Estate Blaenavon, Gwent, NP4 9RL (Biozyme) and ISTA Pharmaceuticals, Inc., a Delaware corporation whose corporate office is situated at 15279 Alton Parkway, Suite 1001, Irvine, California 92618 (ISTA) .
RECITALS
WHEREAS, Biozyme _____________
ISTA Pharmaceuticals, – Palo Alto, California 94306-2155
Attn: Daniel Zimmerman
Fax: (650) 849-7400
Any notice to be given to ISTA will be addressed to:
ISTA Pharmaceuticals, Inc.
15279 Alton Pkwy
Suite 100
Irvine, California 92618 USA
Attn: Lauren Silvernail,
Chief Financial Officer
Fax: (949) 789-7744
With a _____________
ISTA Pharmaceuticals, – parties hereto have caused this Agreement to be executed in duplicate by their respective duly authorized representatives.
Biozyme Laboratories Ltd
By:
Name:
Title:
ISTA Pharmaceuticals, Inc.
By:
Name:
Title:
10
_____________
dt 219767
;
|
Cooley Godward
As referenced in this Technology License Agreement:
Cooley Godward – South Wales
United Kingdom
Attn: John Chesham, Ph.D.
Managing Director
Fax: 44 (0) 14 9579 0678
With a copy to Biozymes counsel:
Cooley Godward LLP
Five Palo Alto Square
3000 El Camino Real
Palo Alto, California 94306-2155
Attn: Daniel Zimmerman
Fax: (650) 849-7400
Any _____________
dt 214135
|
Preview
Full Doc
 | 2004 |
Technology License Agreement
Technology License Agreement (36K)
Doc #389427: Click preview link for longer preview.
Page 1 of 13
TECHNOLOGY LICENSE AGREEMENT
between
EMBL Enterprise Management Technology Transfer GmbH
Boxbergring 107
69126 Heidelberg
represented by the Managing Director
- hereafter EMBLEM -
and
ANADYS PHARMACEUTICALS, INC
. . .
389427
|
Anadys Pharma
As referenced in this Technology License Agreement:
ANADYS PHARMACEUTICALS, INC – 83
AND 230.406.
Page 1 of 13
TECHNOLOGY LICENSE AGREEMENT
between
EMBL Enterprise Management Technology Transfer GmbH
Boxbergring 107
69126 Heidelberg
represented by the Managing Director
- hereafter EMBLEM -
and
ANADYS PHARMACEUTICALS, INC
Delaware
represented by the Managing Director
- hereafter ANADYS -
PREAMBLE
ANADYS desires to employ proprietary technologies developed at the European
Molecular Biology Laboratory (EMBL) -represented by EMBLEM in accordance with
_____________
ANADYS
Pharmaceuticals, Inc – or its designee, EMBLEM Technology
Transfer GmbH and ii) certain other participating individuals as listed on ANNEX
3, a total of 2,090,335 shares of restricted Common Stock of ANADYS
Pharmaceuticals, Inc . representing approximately 9.20% of the share capital. The
grant to EMBLEM includes without limitation, all shares of restricted Common
Stock of ANADYS, Inc. which ANADYS has designated for _____________
ANADYS PHARMACEUTICALS, INC – The
arbitration decision is not subject to appeals.
{PAGE}
Page 10 of 13
Done at Heidelberg the 9th day of January, 2001.
Gabor M. Lamm /s/ Kleanthis G. Xanthopoulos
------------------------- ------------------------------------
EMBLEM ANADYS PHARMACEUTICALS, INC .
EMBLEM
Technology Transfer GmbH
Boxbergring 107
69126 Heidelberg
Germany
ANNEXES:
ANNEX 1 LICENSED PATENTS
ANNEX 2 LICENSED TECHNOLOGY
ANNEX 3 OTHER PARTICIPATING INDIVIDUALS
{PAGE}
Page 11 of 13
ANNEX _____________
ANADYS PHARMACEUTICALS, INC – 120,000 shares of restricted common stock
[...***...] [...***...]
***CONFIDENTIAL TREATMENT REQUESTED
{PAGE}
AMENDMENT TO THE "TECHNOLOGY LICENSE AGREEMENT"
DATED JANUARY 9, 2001
BETWEEN
EMBL ENTERPRISE MANAGEMENT TECHNOLOGY TRANSFER GMBH ("EMBLEM")
AND
ANADYS PHARMACEUTICALS, INC . ("ANADYS")
1. ANADYS and EMBLEM agree to replace the wording of Article 3(4) by the
following wording:
"ANADYS shall direct and control the filing, prosecution and
maintenance of _____________
ANADYS PHARMACEUTICALS, INC – research and commercial purposes.
Heidelberg, Germany the 14th day of November, 2002.
/s/ Gabor M. Lamm /s/ Kleanthis G. Xanthopoulos
------------------------------ ----------------------------------------
Gabor Lamm, Managing Director Kleanthis G. Xanthopoulos, President & CEO
EMBLEM ANADYS PHARMACEUTICALS, INC .
{PAGE}
*** CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS
DOCUMENT (INDICATED BY ASTERISKS) HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION
PURSUANT TO A REQUEST FOR CONFIDENTIAL _____________
dt 1491157
| |
Full Doc
 | 2004 |
Technology License Agreement
Technology License Agreement (13K)
Doc #1262648: This document is immediately available for purchase, but does not have a preview available for viewing.
1262648
| | |